Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 5:05 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,409 | $1.83 | $84,928 | 2,877,777 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 5:04 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
7,144 | $1.83 | $13,074 | 809,090 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 5:54 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
144,250 | $2.1 | $302,925 | 4,326,086 (Indirect Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 5:53 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
50,506 | $2.1 | $106,063 | 1,108,534 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 5:52 pm |
Akebia Therapeutics Inc. | AKBA | Malabre Richard C SVP, Chief Accounting Officer |
30,202 | $2.1 | $63,424 | 408,248 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 5:51 pm |
Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer |
55,621 | $2.1 | $116,804 | 734,879 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-14 4:05 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
12,016 | $1.26 | $15,140 | 651,243 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-14 4:04 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
34,840 | $1.26 | $43,898 | 672,092 (Direct) |
View |
| 2023-08-25 Sale |
2024-05-09 5:27 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
27,000 | $1.15 | $31,050 | 668,840 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 5:49 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
8,661 | $1.58 | $13,684 | 706,932 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 5:48 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
5,974 | $1.58 | $9,439 | 663,259 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 5:47 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,570 | $1.58 | $73,581 | 2,364,436 (Indirect Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 5:46 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
7,169 | $1.58 | $11,327 | 695,840 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 6:03 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
7,411 | $1.52 | $11,265 | 669,233 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 6:02 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
10,744 | $1.52 | $16,331 | 715,593 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 6:01 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
8,367 | $1.52 | $12,718 | 703,009 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 6:00 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
37,733 | $1.52 | $57,354 | 2,411,006 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,489 | $1.68 | $78,102 | 3,353,939 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
24,311 | $1.68 | $40,842 | 1,014,676 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-02-04 5:54 pm |
N/A 2027-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
2,102,900 | $0 | 4,326,086 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 5:53 pm |
N/A 2035-01-31 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
487,200 | $0 | 1,108,534 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 5:52 pm |
N/A 2035-01-31 |
Akebia Therapeutics Inc. | AKBA | Malabre Richard C SVP, Chief Accounting Officer |
213,000 | $0 | 408,248 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 5:51 pm |
N/A 2035-01-31 |
Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer |
487,200 | $0 | 734,879 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 5:48 pm |
N/A 2035-01-31 |
Akebia Therapeutics Inc. | AKBA | Ostrowski Erik SVP, CFO, CBO & Treasurer |
487,200 | $0 | 837,200 (Direct) |
View |
| 2025-01-17 Exercise |
2025-01-22 4:06 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | FRIESON RON Director |
20,100 | $0.45 | 93,800 (Direct) |
View |
| 2025-01-17 Exercise |
2025-01-22 4:06 pm |
2023-06-08 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | FRIESON RON Director |
20,100 | $0 | 93,800 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 4:31 pm |
N/A 2034-06-28 |
Akebia Therapeutics Inc. | AKBA | Ostrowski Erik SVP, CFO, CBO & Treasurer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:20 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | Wolf Myles Director |
75,000 | $0 | 142,681 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:20 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
75,000 | $0 | 170,233 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:19 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director |
75,000 | $0 | 171,029 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:19 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
75,000 | $0 | 162,130 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:19 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | FRIESON RON Director |
75,000 | $0 | 118,700 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:18 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
75,000 | $0 | 118,700 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:18 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
75,000 | $0 | 209,800 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:11 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer |
758,250 | $0 | 758,250 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:11 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Malabre Richard C Chief Accounting Officer |
559,950 | $0 | 559,950 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:11 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
373,300 | $0 | 950,337 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer |
373,300 | $0 | 743,300 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
373,300 | $0 | 900,644 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,508,700 | $0 | 3,353,939 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
505,500 | $0 | 1,014,676 (Direct) |
View |
| 2023-07-31 Option Award |
2023-08-01 4:35 pm |
N/A 2033-07-31 |
Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer |
930,000 | $0 | 930,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:08 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
75,000 | $0 | 88,700 (Direct) |
View |